Cite
HARVARD Citation
White, W. et al. (2014). SAT0260 Biomarkers Associated with Rheumatoid Arthritis Disease Activity Including Joint Damage Correlate with Changes in Clinical Response in Subjects Treated with Mavrilimumab at Doses above 10 Mg. Annals of the rheumatic diseases. p. 687. [Online].